Lectures and seminars OnkPat Friday Seminar: T Cell Receptor Gene Modified T Cells for the Immunotherapy of Cancer
14-11-2025 12:30 pm Add to iCal
Karolinska University Hospital, Solna J3:13 Marc Bygdeman, BioClinicum
Welcome to OnkPat Friday Seminar with Michael Nishimura, Professor at Loyola University Chicago.
Host: Stina Wickström, Department of Oncology-Pathology
Related publications
Nonactivated and IL-7 cultured CD19-specific CAR T cells are enriched in stem cell phenotypes and functionally superior.
Wang SY, Scurti GM, Dalheim AV, Quinn S, Stiff PJ, Nishimura MI
Blood Adv 2024 Jan;8(2):324-335
Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus.
Barisic S, Brahmbhatt EM, Cherkasova E, Spear TT, Savani U, Pierre S, Scurti GM, Chen L, Igboko M, Nadal R, Zeng G, Parry G, Stroncek DF, Highfill S, Dalheim AV, Reger R, Nishimura MI, Childs RW
J Immunother Cancer 2024 Sep;12(9):